Fertility Frontiers: What Is a 'Permitted' Embryo in Law?
By Antony Starza-Allen,
Progress Educational Trust
| 06. 13. 2022
The question of what is a 'permitted embryo' under the legislation governing assisted reproduction in the UK has received increasing scrutiny as technological progress challenges the concept of embryohood. As illustrated at Progress Educational Trust (PET)'s event, 'Fertility Frontiers: What Is a 'Permitted' Embryo in Law?', the answer is not solely concerned with the scope of what is permissible in assisted reproduction but goes to the very core of the UK's legislative approach to emerging reproductive technologies.
Introducing the debate, Sarah Norcross, director of PET, highlighted that while UK fertility law gives confidence and security during scientific change, the definition of an embryo, introduced under the Human Fertilisation and Embryology (HFE) Act 2008, is not fully scientifically aligned. Under the HFE Act 2008, an embryo for use in assisted reproduction must have been created by the fertilisation of an unaltered 'permitted egg' with a 'permitted sperm'. It must have no cells added to it from other sources or have its DNA altered (an exception exists for mitochondrial donation). Recent technological developments have, however, challenged...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...